ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

NCT00283361 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure, Congestive

Interventions

DRUG: ZP120
PROCEDURE: I.v. catherization
PROCEDURE: 6-minutes walk performance
BEHAVIORAL: Dyspnea severity assessment
PROCEDURE: Blood sampling for laboratory tests
PROCEDURE: ECG
PROCEDURE: Physical examination

Sponsor

Zealand Pharma

Collaborators

[object Object]